<DOC>
	<DOCNO>NCT01585324</DOCNO>
	<brief_summary>This open-label , multicenter , phase IV study evaluate relationship drop hemoglobin level sustain virological response patient chronic hepatitis C genotype 1 treat Copegus ( ribavirin ) Pegasys ( peginterferon alfa-2a ) . Patients receive Copegus 1000 mg 1200 mg orally daily Pegasys 180 mcg subcutaneously weekly . Anticipated time study treatment , depend virological response , 48 72 week .</brief_summary>
	<brief_title>A Study The Relationship Between Drop Hemoglobin Sustained Virological Response Patients With Chronic Hepatitis C Treated With Copegus ( Ribavirin ) Pegasys ( Peginterferon Alfa-2a )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age Chronic hepatitis C , genotype 1 Treatmentna√Øve patient relapse failed respond previous combination therapy interferon ribavirin Detectable HCVRNA Fertile male females childbearing potential must agree use two form contraception treatment 6 month treatment end Pregnant breastfeed woman Male partner pregnant woman History evidence medical condition associate chronic liver disease HCV Coinfection active hepatitis A , hepatitis B and/or HIV virus Hepatocellular carcinoma History evidence oesophageal varix condition consistent decompensated liver disease Anemia Any patient increase baseline risk anemia ( e.g . thalassemia , spherocyctosis , history GI bleeding ) History evidence significant cardiovascular disease Kidney disease Severe retinopathy History severe psychiatric disease , especially depression Therapy systemic antiviral , antineoplastic immunomodulatory treatment ( include supraphysiologic dos steroid radiation ) &lt; /= 6 month prior first dose study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>